A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy

Abstract

The risk of rebound hyperbilirubinemia can be quantified according to an infant's gestational age, age at phototherapy initiation, and TSB relative to the treatment threshold at phototherapy termination.